| 20 jaar hiv-combinatietherapie in Nederland K Brinkman, TS Boender, M van der Valk, P Reiss, FP Kroon Nederlands Tijdschrift voor Geneeskunde 161, D1123, 2017 | | 2017 |
| 23rd International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology| S7 J Koopsen, C Russell, M van der Valk, J Schinkel | | |
| 8 weeks of ledipasvir-sofosbuvir for non-cirrhotic patients with HCV genotype 4: A single-arm multicenter phase 3b study (HepNed-001) A Boerekamps, T Vanwolleghem, M van der Valk, E Van den Berk Guido, ... Journal of Hepatology 68, S122-S123, 2018 | | 2018 |
| 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study) A Boerekamps, T Vanwolleghem, M van der Valk, GE van den Berk, ... Journal of Hepatology 70 (3), 554-557, 2019 | 7 | 2019 |
| A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022 THIVTE AMsterdam, A van Sighem, S Hendriks, F Deug, P Zantkuijl, ... Eurosurveillance 28 (40), 2023 | 3 | 2023 |
| A highly virulent variant of HIV-1 circulating in the Netherlands C Wymant, D Bezemer, F Blanquart, L Ferretti, A Gall, M Hall, T Golubchik, ... Science 375 (6580), 540-545, 2022 | 60 | 2022 |
| A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients R Van Leeuwen, C Katlama, RL Murphy, K Squires, J Gatell, A Horban, ... Aids 17 (7), 987-999, 2003 | 269 | 2003 |
| a rash decision R Renckens, M van der Valk The largest Q fever outbreak ever reported 380, 423, 2010 | 2 | 2010 |
| A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy RME Blümer, M van der Valk, M Ackermans, E Endert, MJ Serlie, P Reiss, ... American Journal of Physiology-Endocrinology and Metabolism 297 (5), E1097-E1104, 2009 | 11 | 2009 |
| A single dose of anti-miR-122, RG-101, in CHC patients results in NK cell normalization with no effect on HCV-specific CD8+ T cell function F Stelma, MH van der Ree, MJ Sinnige, A Brown, L Swadling, ... Hepatology (Baltimore, Md.) 66 (1), 57, 2017 | 3 | 2017 |
| A Single Dose of Anti-MIR122 Oligonucleotide RG-101 Results in a less Activated Phenotype of NK Cells in Patients with Chronic Hepatitis C F Stelma, MH van der Ree, MJ Sinnige, JM de Vree, SB Willemse, ... Journal of Hepatology 2 (64), S415-S416, 2016 | | 2016 |
| A single dose of RG-101, a GalNAc-conjugated oligonucleotide targeting mir-122, results in undetectable HCV RNA levels in chronic hepatitis C patients at week 28 of follow-up MH van der Ree, JMD Vree, F Stelma, S Willemse, M van der Valk, ... Hepatology 62, 315A-316A, 2015 | 5 | 2015 |
| A woman with a painful hip M Van der Valk, MH Godfried Netherlands journal of medicine 67 (7), 289-+, 2009 | 4 | 2009 |
| A21 Retrospectively describing hepatitis C virus transmission dynamics and tracking HCV transmission networks in real-time for strategic elimination interventions J Koopsen, C Russell, M van der Valk, J Schinkel Virus Evolution 5 (Supplement_1), vez002. 020, 2019 | 1 | 2019 |
| Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture–recapture analysis for the 2013 to 2016 period TS Boender, EO de Coul, J Arends, M Prins, M van der Valk, ... Eurosurveillance 25 (7), 1900450, 2020 | 3 | 2020 |
| Acute hepatitis C infection among adults with HIV in the Netherlands: a capture-recapture analysis TS Boender, EO de Coul, J Arends, M Prins, M van der Valk, ... medRxiv, 19002097, 2019 | | 2019 |
| Age-related changes in plasma biomarkers and their association with mortality in COVID-19 EHA Michels, B Appelman, J de Brabander, RBE van Amstel, ... European Respiratory Journal 62 (1), 2023 | 11 | 2023 |
| AGEhIV Cohort Study Group Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals … J Schouten, FW Wit, IG Stolte, NA Kootstra, M van der Valk, SE Geerlings, ... Clin Infect Dis 59 (12), 1787-1797, 2014 | 39 | 2014 |
| AGEhIV Cohort Study Group Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and … RA van Zoest, FW Wit, KW Kooij, M van der Valk, J Schouten, NA Kootstra, ... Clin Infect Dis 63 (2), 205-213, 2016 | 5 | 2016 |
| AGEhIV Cohort Study Group Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy RA van Zoest, M van der Valk, FW Wit, I Vaartjes, KW Kooij, JW Hovius, ... Eur J Prev Cardiol 24 (12), 1297-1307, 2017 | 2 | 2017 |
janke schinkelAcademic Medical Center, Department of MicrobiologyVerified email at amc.uva.nl
